A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma.
Qingtao NiChi PanQing GuoPeng WangYan YangWei ZhangShengbin DaiPublished in: Dose-response : a publication of International Hormesis Society (2022)
Lung squamous cell cancer (SCC) and accounts for approximately 20%-30% of all lung cancers. Surgery, chemotherapy and radiotherapy are the main treatments for lung SCC patients. A case with lung SCC patient who was treated using iodine 125 seeds (I-125) because the location of the tumor was adjacent to the great vessels. I-125 is an ideal brachytherapy for lung SCC patients with large masses who lost the chance of operation. I-125 is an adjuvant therapy, combined with chemotherapy and molecular targeting therapy might serve to improve the prognosis of lung SCC patients.
Keyphrases
- squamous cell carcinoma
- end stage renal disease
- newly diagnosed
- locally advanced
- squamous cell
- ejection fraction
- prognostic factors
- peritoneal dialysis
- minimally invasive
- stem cells
- early stage
- magnetic resonance
- patient reported outcomes
- case report
- coronary artery disease
- drug delivery
- young adults
- coronary artery bypass
- percutaneous coronary intervention
- acute coronary syndrome
- contrast enhanced
- dual energy